GSK Investigational Site
Davao City 8000
0 studies enrolling now · 8 studies all time
What they study most
Acute Coronary Syndrome, Asthma, Diabetes Mellitus, Type 2, Lupus Nephritis, Pulmonary Disease, Chronic Obstructive, Systemic Lupus Erythematosus
Studies at this site
- Belimumab Assessment of Safety in SLE — Completed
- Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis — Completed
- Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus — Completed
- Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease — Completed
- 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old — Completed
- SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. — Completed
- A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) — Completed
- The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial — Completed